国家组织药品带量采购政策的降价持续性研究

Objectives: To analyze the continuous effect of the price reduction of the national drug procurement policy and explore measures for the stable operation of centralized drug prices. Methods: The procurement data of the first five batches of centralized drugs in medical institutions nationwide in the comprehensive service platform for centralized drug procurement were used to describe the price changes of centralized procurement drugs by using the Laspeyres price index and the Fisher price index. Results: The price reduction of selected drugs in centralized procurement reached 50%-85%, and the price reduction of unselected drugs with the same generic name reached 10%-40%, and the price reduction effect was long-lasting, and the price of some drugs increased after selection. Conclusion: The national centralized procurement policy can not only sustainably and significantly reduce the price of selected drugs, but also reduce the price of unselected drugs with the same generic name. It is recommended to build a monitoring and early warning system for the operation of centralized drug prices to strengthen drug price monitoring and expand the scope of centralized drug procurement.